Cite
Diabetic Ketoacidosis in a Patient with Type 2 Diabetes After Initiation of Sodium-Glucose Cotransporter 2 Inhibitor Treatment.
MLA
Storgaard, Heidi, et al. “Diabetic Ketoacidosis in a Patient with Type 2 Diabetes After Initiation of Sodium-Glucose Cotransporter 2 Inhibitor Treatment.” Basic & Clinical Pharmacology & Toxicology, vol. 118, no. 2, Feb. 2016, pp. 168–70. EBSCOhost, https://doi.org/10.1111/bcpt.12457.
APA
Storgaard, H., Bagger, J. I., Knop, F. K., Vilsbøll, T., & Rungby, J. (2016). Diabetic Ketoacidosis in a Patient with Type 2 Diabetes After Initiation of Sodium-Glucose Cotransporter 2 Inhibitor Treatment. Basic & Clinical Pharmacology & Toxicology, 118(2), 168–170. https://doi.org/10.1111/bcpt.12457
Chicago
Storgaard, Heidi, Jonatan I Bagger, Filip K Knop, Tina Vilsbøll, and Jørgen Rungby. 2016. “Diabetic Ketoacidosis in a Patient with Type 2 Diabetes After Initiation of Sodium-Glucose Cotransporter 2 Inhibitor Treatment.” Basic & Clinical Pharmacology & Toxicology 118 (2): 168–70. doi:10.1111/bcpt.12457.